Information Provided By: 
Fly News Breaks for January 20, 2016
FLDM
Jan 20, 2016 | 06:53 EDT
Cowen analyst Doug Schenkel downgraded Fluidigm to Market Perform following the release of preliminary Q4 and 2015 estimates. Schenkel said revenue estimates will likely need to be cut more than previously expected due to C1 "doublet" issues and recent competitive entries in to the single cell genomics sample prep field, and less likely multiple expansion near-term. The analyst lowered his price target on Fluidigm shares to $8.50 from $13.
News For FLDM From the Last 2 Days
There are no results for your query FLDM
